D
Predictive Oncology Inc. POAI
$0.9999 $0.02632.70%
Recommendation
Sell
Prev Close
$0.9736
Volume
124,672
Avg Vol (90D)
3,271,480
Market Cap
$8.70M
Dividend & Yield
--
52-Week Range
$0.55 - $3.06
P/E (TTM)
--
EPS (TTM)
-$2.53
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Good
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Predictive Oncology Ends Merger Talks with Renovaro
4/7/2025 - TipRanks Financial Blog
Renovaro says Predictive Oncology terminates merger transaction
4/4/2025 - Seeking Alpha - Healthcare
Renovaro says Predictive Oncology terminates merger transaction
4/4/2025 - SeekingAlpha.com: All News
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
4/4/2025 - GuruFocus
Renovaro says Predictive Oncology terminates merger transaction
4/4/2025 - TipRanks Financial Blog
Renovaro says Predictive Oncology terminates merger transaction
4/4/2025 - The Fly
Renovaro says Predictive Oncology terminated merger agreement
4/4/2025 - The Fly
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
4/4/2025 - Globe Newswire
Predictive Oncology Reports 2024 Financial Results and Merger Plans
4/2/2025 - TipRanks Financial Blog
Predictive Oncology GAAP EPS of -$1.99, revenue of $1.62M
4/1/2025 - SeekingAlpha.com: All News
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
4/1/2025 - GuruFocus
Predictive Oncology reports FY24 EPS ($1.99) vs. ($2.99) last year
4/1/2025 - The Fly
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
4/1/2025 - Globe Newswire
Predictive Oncology (POAI) Uses AI to Slash Drug Discovery Timelines & Boost Cancer Research
3/27/2025 - Insider Monkey
Top 8 AI News Updates Driving Markets Today
3/25/2025 - Insider Monkey
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen ...
3/25/2025 - GuruFocus
Predictive Oncology developed predictive models from 21 compounds from NPDC
3/25/2025 - The Fly
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
3/25/2025 - Globe Newswire
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries
3/20/2025 - GuruFocus
Predictive Oncology completes sale of Skyline Medical assets to DeRoyal
3/20/2025 - The Fly
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries
3/20/2025 - Globe Newswire
Predictive Oncology Inc. (NASDAQ:POAI) Short Interest Down 26.1% in February
3/5/2025 - Ticker Report
Renovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What's Next for Cancer and HIV Treatments?
3/4/2025 - Insider Monkey
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
3/3/2025 - GuruFocus
Renovaro completes first milestone payment for Predictive Oncology deal
3/3/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$1.66M
EBITDA (TTM)
-$11.46M
EBIT (TTM)
-$11.86M
Net Income (TTM)
-$12.66M
Balance Sheet
Total Assets (Q)
$4.97M
Total Debt (Q)
$2.13M
Total Liabilities (Q)
$5.18M
Book Value Per Share (Q)
-$0.0305
Cash Flow
Cash from Operations (TTM)
-$8.78M
Cash from Investing (TTM)
-$9.50K
Cash from Financing (TTM)
$3.05M
Net Change in Cash (TTM)
-$5.74M
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
1.86
7-Day Total Return
-28.58%
30-Day Total Return
-28.06%
60-Day Total Return
-15.97%
90-Day Total Return
24.21%
Year to Date Total Return
8.68%
1-Year Total Return
-43.83%
2-Year Total Return
-82.14%
3-Year Total Return
-93.47%
5-Year Total Return
-96.82%
52-week Low
Oct 15, 2024 - $0.55
52-week High
Jan 06, 2025 - $3.06
Valuation
Market Cap
$8.70M - Nano Cap
Enterprise Value
$10.09M
Price/Sales (TTM)
3.93
Price/Book (Q)
-31.92
Dividends and Shares
Shares Outstanding
6.68M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.predictive-oncology.com
Phone Number
412 432 1500
Address
91 43rd Street
Pittsburgh, PA 15201
Country
United States
Year Founded
2002
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through... more
NASDAQ 04/11/2025 4:00PM Eastern Quotes delayed
Weiss Ratings